As seen on:
As seen on:
Latest Articles
Play your own investment version of the popular squid game, on your own terms.
Last call to join our free webinar!
We offer a slew of updates from five companies to whet your appetite.
Although the CPF offers a decent return for parking your funds, here are three companies that offer higher dividend yields.
Fintech companies promise to usher in a new era of convenience and speed. Here’s why you should latch on to this fast-growing trend.
We compare two industrials with the same sponsor to determine which makes a better investment choice.
Popular
Rights issues are often used as a method for companies to raise money. Should investors reserve some money to apply for them?
Not all REITs fared poorly during this downturn. Here are five that reported a sharp year on year jump in their distributions.
This week’s round-up talks about a REIT acquisition cum divestment, a fintech player bidding for a Malaysian digital bank licence, and a divestment by a real estate giant.
Blue-chip conglomerate Keppel is embarking on a potential combination that could transform the company. Here are four things you should know.
Stocks
The healthcare glove manufacturer continues to announce amazing numbers.
These companies can be relied upon for a steady stream of income during these turbulent times.
The financial technology company has failed in its bid to win a digital banking licence.
Moderna and BioNTech’s share prices have increased by 621% and 237% year-to-date. Is it too late to get in on these COVID-19 vaccine frontrunners?